JP2002510712A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002510712A5 JP2002510712A5 JP2000542438A JP2000542438A JP2002510712A5 JP 2002510712 A5 JP2002510712 A5 JP 2002510712A5 JP 2000542438 A JP2000542438 A JP 2000542438A JP 2000542438 A JP2000542438 A JP 2000542438A JP 2002510712 A5 JP2002510712 A5 JP 2002510712A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- antibody
- iii
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 201000000980 schizophrenia Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000000698 schizophrenic effect Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12392598 | 1998-04-02 | ||
| IL123925 | 1998-04-02 | ||
| PCT/IL1999/000190 WO1999051725A2 (en) | 1998-04-02 | 1999-03-30 | Assay for the diagnosis of schizophrenia based on a new peptide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002510712A JP2002510712A (ja) | 2002-04-09 |
| JP2002510712A5 true JP2002510712A5 (enExample) | 2006-05-25 |
| JP4364433B2 JP4364433B2 (ja) | 2009-11-18 |
Family
ID=11071395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000542438A Expired - Lifetime JP4364433B2 (ja) | 1998-04-02 | 1999-03-30 | 新規なペプチドに基づく精神分裂病の診断のためのアッセイ |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7098304B1 (enExample) |
| EP (1) | EP1068303B1 (enExample) |
| JP (1) | JP4364433B2 (enExample) |
| CN (1) | CN1171995C (enExample) |
| AR (1) | AR014811A1 (enExample) |
| AT (1) | ATE309335T1 (enExample) |
| AU (1) | AU3165599A (enExample) |
| BR (1) | BR9909308B1 (enExample) |
| CA (1) | CA2324380C (enExample) |
| DE (1) | DE69928236T2 (enExample) |
| IL (1) | IL138746A (enExample) |
| TW (1) | TW581812B (enExample) |
| WO (1) | WO1999051725A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002037105A1 (en) * | 2000-10-31 | 2002-05-10 | Japan As Represented By President Of Niigata University | Diagnostic kit for schizophrenia |
| JP5048205B2 (ja) | 2001-03-21 | 2012-10-17 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 精神分裂病の診断のための新規ペプチド |
| CN1300588C (zh) * | 2005-02-28 | 2007-02-14 | 上海交通大学 | 用于精神分裂症诊断的血浆特异性蛋白获取方法及应用 |
| WO2007091881A2 (en) * | 2005-04-29 | 2007-08-16 | Leiden University Medical Center | Methods and means for detection of mycobacterium leprae infections |
| JP2018524595A (ja) * | 2015-07-14 | 2018-08-30 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | 統合失調症の診断で使用するためのペプチドの組み合わせ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994026107A1 (en) * | 1993-05-13 | 1994-11-24 | New York University | Psychosis protecting nucleic acid, peptides, compositions and method of use |
| US6008001A (en) * | 1993-11-05 | 1999-12-28 | Yeda Research And Development Co. Ltd. | Diagnosis of the susceptibility of contracting schizophrenia |
| CA2184602A1 (en) * | 1994-03-01 | 1995-09-08 | Meir Shinitzky | Assay for the diagnosis of schizophrenia |
-
1999
- 1999-03-30 DE DE69928236T patent/DE69928236T2/de not_active Expired - Lifetime
- 1999-03-30 AT AT99913557T patent/ATE309335T1/de not_active IP Right Cessation
- 1999-03-30 US US09/647,457 patent/US7098304B1/en not_active Expired - Lifetime
- 1999-03-30 EP EP99913557A patent/EP1068303B1/en not_active Expired - Lifetime
- 1999-03-30 WO PCT/IL1999/000190 patent/WO1999051725A2/en not_active Ceased
- 1999-03-30 AU AU31655/99A patent/AU3165599A/en not_active Abandoned
- 1999-03-30 BR BRPI9909308-1A patent/BR9909308B1/pt not_active IP Right Cessation
- 1999-03-30 CN CNB998059951A patent/CN1171995C/zh not_active Expired - Fee Related
- 1999-03-30 CA CA002324380A patent/CA2324380C/en not_active Expired - Fee Related
- 1999-03-30 JP JP2000542438A patent/JP4364433B2/ja not_active Expired - Lifetime
- 1999-03-31 TW TW088105128A patent/TW581812B/zh not_active IP Right Cessation
- 1999-03-31 AR ARP990101492A patent/AR014811A1/es not_active Application Discontinuation
-
2000
- 2000-09-28 IL IL138746A patent/IL138746A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010322085B2 (en) | Peptides and methods for the detection of Lyme disease antibodies | |
| CA2851540C (en) | Peptides and methods for the detection of lyme disease antibodies | |
| US5618533A (en) | Flagellin-based polypeptides for the diagnosis of lyme disease | |
| Clark et al. | Pellicle receptors for Actinomyces viscosus type 1 fimbriae in vitro | |
| EP2501718B1 (en) | Peptides, devices, and methods for the detection of ehrlichia antibodies | |
| JP2002542157A5 (enExample) | ||
| JP2005522210A5 (enExample) | ||
| CA2370493A1 (en) | Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof | |
| RU2009143671A (ru) | Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков | |
| AU2013329025A1 (en) | Peptides, devices, and methods for the detection of Ehrlichia antibodies | |
| EP3299817B1 (en) | Compositions and methods for screening for lyme disease | |
| JP2008515388A5 (enExample) | ||
| DE69224134T2 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
| JP2002510712A5 (enExample) | ||
| KR101143726B1 (ko) | 생체활성의 무손상 부갑상선 호르몬 (ｐｔｈ) 1-84에 대한 선택적 결합 특이성을 지니는 항체 및 이를 생성하기 위한 펩티드 항원 | |
| JP2003510559A5 (enExample) | ||
| WO2017125007A1 (zh) | 用于诊断活动性结核的方法和试剂盒 | |
| EP0985931A3 (en) | Recombinant antigen immunoassay for the diagnosis of syphilis | |
| Fritz et al. | Specificity of antisera from Lewis rats immunized with encephalitogenic fragment 43–88 of guinea pig myelin basic protein | |
| EP1963858B1 (en) | A bioassay and peptides for use therein | |
| FI104219B (fi) | Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi | |
| DE19624620C2 (de) | Verfahren zur Bestimmung von Anti-Sp 100-Antikörpern aus Körperflüssigkeiten | |
| AU633633B2 (en) | Agglutination assay | |
| CA2441925A1 (en) | Novel peptides for the diagnosis of schizophrenia | |
| Prokopchuk et al. | One-way humoral immune cross-reactivity between bovine spinal cord protein and bovine myelin basic protein |